How Wegovy and Mounjaro Doses Actually Compare
Understanding Wegovy Mounjaro Equivalent Doses: Key Mechanism Differences
When comparing Wegovy mounjaro equivalent doses, it's essential to understand that these aren't directly comparable medications with simple dose conversions. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual-action approach means Mounjaro works through two distinct pathways to influence appetite and blood sugar regulation, whereas Wegovy focuses specifically on GLP-1 pathways.
The dosing schedules reflect these fundamental differences in how each prescription-only medicine works. Wegovy follows a structured 5-dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), while Mounjaro uses 6 dose levels starting higher at 2.5mg and potentially reaching 15mg. Both medications require careful dose escalation to minimise side effects, but the timelines and mg amounts aren't equivalent due to their different mechanisms of action.
Wegovy vs Mounjaro Pricing: Transparent Cost Comparison
At EverydayMeds, we provide both treatments with clear pricing at every stage of your journey. Wegovy starts with our 0.25mg starter dose at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Our bundles offer convenience for continuous treatment, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99.
New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices. Mounjaro pricing follows a different structure due to its distinct dosing schedule, but both treatments are available through the same streamlined clinical assessment process. Your prescriber will consider factors like your medical history, current medications, and weight management goals when recommending the most suitable option alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence: STEP Trials vs SURMOUNT Studies
Wegovy's clinical profile comes from the comprehensive STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved an average of ~clinically studied weight loss at 68 weeks in STEP 1, compared to ~2.4% with placebo. The STEP 5 trial demonstrated sustained results with ~clinically studied weight loss maintained at 2 years, while the SELECT cardiovascular outcomes study showed a 20% reduction in major cardiovascular events.
Mounjaro's evidence base stems from the SURMOUNT trials, which evaluated tirzepatide's dual-hormone approach in weight management. However, direct comparison of trial results isn't appropriate due to different study designs, patient populations, and endpoints between the STEP and SURMOUNT programmes. Both medications demonstrated efficacy when used as prescribed alongside lifestyle modifications, with your prescriber able to discuss which clinical profile may be most relevant to your individual circumstances.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy's active ingredient, semaglutide, functions as a GLP-1 receptor agonist that mimics the action of your body's natural incretin hormone. Once injected weekly using the convenient FlexTouch pen device, semaglutide binds to GLP-1 receptors in your brain's appetite control centres, helping to reduce hunger signals and promote feelings of fullness after smaller meals. This mechanism may also help reduce food cravings and slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety. The medication works most effectively when combined with a structured approach to nutrition and regular physical activity, as the reduced appetite provides an opportunity to establish healthier eating patterns. Understanding this mechanism helps explain why Wegovy mounjaro equivalent doses can't be directly converted, as each medication influences different physiological pathways despite both supporting weight management goals.
Streamlined Ordering Process: Assessment to Delivery
Getting started with either Wegovy or Mounjaro through EverydayMeds follows the same efficient process, beginning with our comprehensive 3-minute online clinical assessment. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), evaluating your medical history, current medications, and weight management goals to determine the most appropriate treatment option. Once approved, your prescription-only medicine is dispatched via next-day delivery using our temperature-controlled cold-chain system to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the process, from initial assessment through ongoing prescription management. Whether you choose Wegovy or Mounjaro, you'll receive the same professional clinical oversight and convenient delivery service that makes starting treatment straightforward and stress-free.
Storage and Practical Considerations: Real-World Usage
Storage requirements present a notable practical difference when comparing wegovy mounjaro equivalent doses and day-to-day usage. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability makes it more convenient for travel, work schedules, or temporary storage situations. The injection schedule remains weekly for both treatments, with each using pre-filled pen devices designed for subcutaneous injection into the thigh, abdomen, or upper arm. Dose escalation timelines differ significantly: Wegovy follows 4-week intervals between increases, while Mounjaro typically escalates every 4 weeks but may require longer periods based on individual tolerance and prescriber recommendations.
Dual Hormone vs Single Hormone: Choosing Your Approach
The fundamental difference in wegovy mounjaro equivalent doses stems from their distinct hormonal mechanisms, which may appeal to different patient profiles and treatment goals. Wegovy's focused GLP-1 approach provides a well-established pathway that has been extensively studied in weight management, with predictable dose escalation and a clear understanding of how semaglutide influences appetite regulation. This single-hormone focus may suit patients who prefer a more straightforward mechanism or those who have specific medical considerations that make dual-pathway activation less suitable.
Mounjaro's dual GIP and GLP-1 agonism represents a newer approach that targets multiple pathways simultaneously, potentially offering different benefits for patients whose weight management challenges involve complex metabolic factors. The choice between single and dual hormone approaches isn't about one being superior, but rather about which mechanism aligns better with your individual physiology, medical history, and treatment preferences. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which approach offers the most appropriate fit for your circumstances.
Expert Clinical Support: Making the Right Choice
Rather than trying to determine wegovy mounjaro equivalent doses on your own, working with qualified healthcare professionals ensures you receive the most appropriate treatment for your individual circumstances. Our clinical team at EverydayMeds evaluates numerous factors including your BMI, weight-related health conditions, medication history, lifestyle considerations, and personal preferences when recommending between Wegovy and Mounjaro. The decision extends beyond simple dose comparisons to encompass your entire weight management strategy, including how each medication integrates with dietary changes, exercise plans, and ongoing medical monitoring.
Both treatments are prescription-only medicines that require ongoing clinical oversight, with regular check-ins to assess progress, adjust dosing as needed, and address any concerns that arise during treatment. Your prescriber can also provide guidance on optimising lifestyle factors that enhance medication effectiveness, ensuring you receive comprehensive support throughout your weight management journey. With transparent pricing, convenient delivery, and professional clinical oversight, EverydayMeds makes accessing either treatment option straightforward while maintaining the highest standards of pharmaceutical care.
Ready to start your weight management journey with professional clinical support? Browse our complete range of treatments at https://everydaymeds.co.uk/collections/weight-loss, where you can compare options, read detailed information, and begin your clinical assessment today. Our discount codes FIRST40 (new customers) and DOSE25 (returning customers) are applied at checkout to ensure you receive the best available pricing. Whether you choose Wegovy or Mounjaro, you'll receive the same commitment to clinical excellence, convenient service, and ongoing support that makes EverydayMeds the trusted choice for prescription weight management solutions. Take the first step toward your goals with confidence, knowing you have expert guidance and genuine pharmaceutical-grade medications supporting your success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
